Patents by Inventor Isabel SOLE FONT

Isabel SOLE FONT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa
    Patent number: 11844860
    Abstract: A pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa as active ingredients and one or more excipients. Once dispersed in an aqueous medium, melevodopa is completely dissolved, and carbidopa is present as nanoparticles.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: December 19, 2023
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Ricardo Inacio, Mark Saunders, Bhanvi Mehta, Kathrin Muehlhoelzl-Odoerfer, Isabel Sole Font, Grazia Caivano
  • A PHARMACEUTICAL FORMULATION FOR INTRADUODENAL ADMINISTRATION COMPRISING MELEVODOPA AND CARBIDOPA
    Publication number: 20210007984
    Abstract: A pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa as active ingredients and one or more excipients. Once dispersed in an aqueous medium, melevodopa is completely dissolved, and carbidopa is present as nanoparticles.
    Type: Application
    Filed: February 21, 2019
    Publication date: January 14, 2021
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Ricardo INACIO, Mark SAUNDERS, Bhanvi MEHTA, Kathrin MUEHLHOELZL-ODOERFER, Isabel Sole FONT, Grazia CAIVANO
  • NANOPARTICLES COMPRISING A STABILIZED BORONIC ACID COMPOUND
    Publication number: 20180243217
    Abstract: The present invention provides nanoparticles comprising at least one boronic acid compound and at least one stabilizing agent for the at least one boronic acid compound and/or a reaction product of the at least one boronic acid compound and the at least one stabilizing agent, whereby the nanoparticles have a particle size of about 10 to about 1000 nm. The present invention also provides a pharmaceutical composition comprising these nanoparticles and a method for the preparation of these nanoparticles and the respective pharmaceutical compositions. In addition, the present invention provides nanoparticles and pharmaceutical compositions for the treatment of several disorders, especially multiple myeloma, preferably by parenteral administration.
    Type: Application
    Filed: March 11, 2016
    Publication date: August 30, 2018
    Inventors: Kathrin Ines MÜHLHÖLZL-ODÖRFER, Elke HORSTKOTTE, Sabine WEITENSTEINER, Isabel SOLE FONT, Akif Emre TÜRELI